1Sato T, Asanuma Y, Hashimoto M, et al. Efficacy of hepatic arterial infusion of prostaglandin E1 in the tyreatment of postoperative acute liver failure-report of a case [J]. Hepatogastroenterology 2000,47:846-850.
2Kondrup T, Almdal H, Vilatrup H et al. High volume plasma exchange in fulminant hepatic failure [J]. Int J Artif Organs ,1992;15(11):669-676.
3Agish T, Nakagawa Y, Terakoka S, et al. Plasma exchange as a rescue strategy for hepatic failure [J]. ASAIO J, 1994;40(1):77-79.
4Sugihara T, Malchesky PS, Nose Y. Artifieal liver: state of the art [J]. Dig Dis Sci,1991,36(9):1327-1340.
5Hodgson H J F. Artificial livers-What's keeping them [J]. Gut, 1995,36:168-170.
6Yoshiba M, Inoue K, Sekiyama K ,et al. Favorable effect of new artificial liver supportion survival of patients with fulminant hepatic failure [J]. Artif Organs,1996,20(11):1169-1171.
7Watanabe FD, Mullon CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. Aphase I clinical trial [J]. Ann Surg, 1997,225:484-487.
8Fujita Y,Ohiwa T,Kubota Y,et al. Clinical trial of plasmapheresis in hepatic failure [J]. ASAIO,1982,28(4):225.
9Okamoto M, Abe T, Shouno M, et al. A case of thrombotic thrombocytopenin purpura refractory to plasma exchange [J]. Ther Apher 2001,5:49-53.
10Desilvestro G, Marson P, Brandolese R, et al. A single institution's experience (1982-1999) with plasma- exchange therapy in patients with fulminant hepatic failure [J]. Int J Artif Organs,2000,23:454-461.
